Search research articles
Contact Us
Filters
Showing results (171-180 of 397) with videos related to
Page
of 40
Sort By:
Brain Research
|
January 21, 2000
Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain
J D Oh, K Chartisathian, T N Chase, et al.
Archives of Neurology
|
July 1, 1986
Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86
G Bruno, E Mohr, M Gillespie, et al.
Transactions of the American Neurological Association
|
January 1, 1976
The circadian pattern of catcholamine metabolites and cAMP in the cerebrospinal fluid of subhuman primates
M Perlow, E Gordon, M Ebert, et al.
Brain Research
|
May 29, 1992
Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin
T M Engber, R C Boldry, S Kuo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1987
Cognitive concomitants of dopamine system stimulation in parkinsonian patients
E Mohr, G Fabbrini, S Ruggieri, et al.
Journal of Clinical and Experimental Neuropsychology
|
March 1, 1990
Impairment of central auditory function in Alzheimer's disease
E Mohr, C Cox, J Williams, et al.
Functional Neurology
|
October 1, 1988
Motor response complications in advanced Parkinson's disease
T N Chase, J L Juncos, G Fabbrini, et al.
European Journal of Pharmacology
|
April 9, 1986
Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions
P Barone, T A Davis, A R Braun, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1986
Magnetic resonance imaging in Huntington disease
J T Simmons, B Pastakia, T N Chase, et al.
Neurology
|
April 1, 1988
No response to high-dose muscarinic agonist therapy in Alzheimer's disease
M M Mouradian, E Mohr, J A Williams, et al.
Page
of 40
Search research articles
Search
Showing results (171-180 of 397) with videos related to
Sort By:
Page
of 40
Brain Research
|
January 21, 2000
Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain
J D Oh, K Chartisathian, T N Chase, et al.
Archives of Neurology
|
July 1, 1986
Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86
G Bruno, E Mohr, M Gillespie, et al.
Transactions of the American Neurological Association
|
January 1, 1976
The circadian pattern of catcholamine metabolites and cAMP in the cerebrospinal fluid of subhuman primates
M Perlow, E Gordon, M Ebert, et al.
Brain Research
|
May 29, 1992
Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin
T M Engber, R C Boldry, S Kuo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1987
Cognitive concomitants of dopamine system stimulation in parkinsonian patients
E Mohr, G Fabbrini, S Ruggieri, et al.
Journal of Clinical and Experimental Neuropsychology
|
March 1, 1990
Impairment of central auditory function in Alzheimer's disease
E Mohr, C Cox, J Williams, et al.
Functional Neurology
|
October 1, 1988
Motor response complications in advanced Parkinson's disease
T N Chase, J L Juncos, G Fabbrini, et al.
European Journal of Pharmacology
|
April 9, 1986
Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions
P Barone, T A Davis, A R Braun, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1986
Magnetic resonance imaging in Huntington disease
J T Simmons, B Pastakia, T N Chase, et al.
Neurology
|
April 1, 1988
No response to high-dose muscarinic agonist therapy in Alzheimer's disease
M M Mouradian, E Mohr, J A Williams, et al.
Page
of 40